ArticleTherapeutics and clinical risk management2013

Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.

Claudio Gasperini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.